Gencell Ltd
GNCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.05 | -0.03 | 0.00 |
| FCF Yield | -116.69% | -83.05% | -48.33% | -5.98% |
| EV / EBITDA | -0.40 | -1.39 | -1.65 | -16.34 |
| Quality | ||||
| ROIC | -68.96% | -57.45% | -29.24% | -26.61% |
| Gross Margin | -9.92% | -106.29% | -34.19% | -75.91% |
| Cash Conversion Ratio | 0.94 | 0.90 | 0.60 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.86% | -5.49% | 177.34% | 67.75% |
| Free Cash Flow Growth | 30.27% | 2.12% | -46.34% | -64.14% |
| Safety | ||||
| Net Debt / EBITDA | 0.53 | -0.14 | 0.08 | 0.16 |
| Interest Coverage | -79.73 | -373.56 | -188.06 | -23.47 |
| Efficiency | ||||
| Inventory Turnover | 4.02 | 2.60 | 3.06 | 6.69 |
| Cash Conversion Cycle | 386.68 | 421.12 | 293.12 | 137.46 |